Cassiopea

Cassiopea S.p.A.
Stock Exchange SIX Swiss Exchange
EPS
CHF1.46
Market Cap
CHF442 M
Shares Outstanding
10 M
Public Float
4.33 M

Profile

Address
Via Cristoforo Colombo, 1
Milan Milan 20020
Italy
Employees -
Website http://www.cassiopea.com
Updated 07/08/2019
Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It engages in developing and commercializing and medical dermatology products focusing on the topical treatment of acne, androgenic alopecia, and genital warts. The company products include Winlevi, Breezula, CB-06-02 and CB-06-01.

Financials

View All

Diana Harbort
Chief Executive Officer & Executive Director
Jan Egbert de Vries
Non-Executive Chairman